Primary and recurrent early stage laryngeal cancer: Preliminary results of 2-[fluorine 18]fluoro-2-deoxy-D-glucose pet imaging

Radiology

Volumn 212, Issue 3, 1999, Pages 799-802

  Lowe, Val J ^a   Kim, Han ^a   Boyd, James H ^a   Elsenbeis, John F ^a   Dunphy, Frank R ^a   Fletcher, James W ^a  

^a SAINT LOUIS UNIVERSITY   (United States)

Author keywords

Emission CT (ECT), comparative studies; Fluorine, radioactive; Head and neck neoplasms; Head and neck neoplasms, emission CT (ECT); Larynx, neoplasms

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RECURRENCE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; LARYNX CANCER; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

EID: 0032826578     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.212.3.r99se26799     Document Type: Article

References (16)

1. Thabet HM, Sessions DG, Gado MH, Gnepp DA, Harvey JE, Talaat M. Comparison of clinical evaluation and computed tomographic diagnostic accuracy for tumors of the larynx and hypopharynx. Laryngoscope 1996; 106:589-594.
2. Charlin B, Brazeau LL, Guerrier B, Leduc C. Assessment of laryngeal cancer: CT scan versus endoscopy. J Otolaryngol 1989; 18:283-288.
3. Kolbenstvedt A, Charania B, Natvig K, Tausjo J. Computed tomography in T1 carcinoma of the larynx. Acta Radiol 1989; 30:467-469.
4. Warburg O. The metabolism of tumors. New York, NY: Smith, 1931; 129.
5. Flier JS, Mueckler MM, Usher P, Lodish HF. Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science 1987; 235:1492-1495.
6. Gallagher BM, Fowler JS, Gutterson NI, MacGregor RR, Wan CN, Wolf AP. Metabolic trapping as a principle of radiopharmaceutical design: some factors responsible for the biodistribution of [18F] 2-deoxy-2-fluoro-D-glucose. J Nucl Med 1978; 19:1154-1161.
7. Bailet JW, Sercarz JA, Abemayor E, Anzai Y, Lufkin RB, Hoh CK. The use of positron emission tomography for early detection of recurrent head and neck squamous cell carcinoma in postradiotherapy patients. Laryngoscope 1995; 105:135-139.
8. Anzai Y, Carroll WR, Quint DJ, et al. Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses. Radiology 1996; 200:135-141.
9. Austin JR, Wong FC, Kim EE. Positron emission tomography in the detection of residual laryngeal carcinoma. Otolaryngol Head Neck Surg 1995; 113:404-407.
10. Lowe VJ, DeLong DM, Hoffman JM, Coleman RE. Optimum scanning protocol for FDG-PET evaluation of pulmonary malignancy. J Nucl Med 1995; 36:883-887.
11. Lowe VJ, Duhaylongsod FG, Patz EF, et al. Pulmonary abnormalities and PET data analysis: a retrospective study. Radiology 1997; 202:435-439.
12. Mukherji SK, Mancuso AA, Mendenhall W, Kotzur IM, Kubilis P. Can pretreatment CT predict local control of T2 glottic carcinomas treated with radiation therapy alone? AJNR 1995; 16:655-662.
13. Greven KM, Williams DW, Keyes JJ, McGuirt WF, Watson NJ, Case LD. Can positron emission tomography distinguish tumor recurrence from irradiation sequelae in patients treated for larynx cancer? Cancer J Sci Am 1997; 3:353-357.
14. Lowe VJ, Hebert ME, Hawk TC, Anscher MS, Coleman RE. Chest wall FDG accumulation in serial FDG-PET images in patients being treated for bronchogenic carcinoma with radiation (abstr). J Nucl Med 1994; 35:76P.
15. Rege SD, Chaiken L, Hoh CK, et al. Change induced by radiation therapy in FDG uptake in normal and malignant structures of the head and neck: quantitation with PET. Radiology 1993; 189:807-812.
16. Lowe V, Dunphy F, Varvares M, et al. Evaluation of chemotherapy response in patients with advanced head and neck cancer using FDG-PET. Head Neck 1997; 19:666-674.